Paraquat Lawsuit Settlement Amounts

Nguyen Injury Lawyer is actively representing individuals in Paraquat lawsuits across the country. This page offers current news and updates regarding Paraquat litigation in both state and federal courts. We also provide our insights on the trajectory of this litigation and offer potential settlement payout projections for viable Paraquat claims.

Individuals diagnosed with Parkinson’s disease due to Paraquat exposure are seeking clarity on the potential settlement amounts they might receive. The projected Paraquat settlement values are subject to change as the litigation progresses. Our attorneys will routinely update this page with revised payout projections.

If you believe you have a Paraquat claim, it is essential to prepare your case promptly. Contact Nguyen Injury Lawyer today at (713) 747-7777 for a free online consultation or visit our contact page at https://www.nguyeninjurylawyer.com/contact.

Paraquat Lawsuit Updates 2026

Paraquat Deadlines Extended (Again)

February 6, 2026

Citing ongoing settlement discussions, the MDL judge has again extended the stay on case-specific deadlines, initially established in January 2025, through March 6, 2026. The judge has indicated that this matter will be reviewed again at that time to determine whether the stay should be extended further.

Syngenta and Chevron Settle First Case Headed to Trial – Hardly a Surprise

January 29, 2026

Syngenta and Chevron have reached a confidential settlement in the first Paraquat Parkinson’s disease case scheduled for trial in Philadelphia.

This case was slated to be the first bellwether trial in the Philadelphia Paraquat Products Litigation and was resolved just before jury selection. The settlement terms remain confidential. The court has stated that while this particular case is resolved, the larger Paraquat mass tort is still active, with additional trials scheduled for April and later in the year.

Syngenta and Chevron are clearly motivated to avoid a jury trial, especially in Philadelphia. Their defense strategy has consistently involved aggressive motion practice and discovery tactics. However, they recognize the potential impact of presenting real evidence and witnesses to a jury.

The settlement is confidential, but settling the first bellwether case at the last minute typically requires a significant payment. Forgoing the opportunity to present this case before a Philadelphia jury comes at a premium.

Snow Pushes Back Paraquat Trial

January 26, 2026

Due to snow, the trial scheduled to begin today has been postponed. A new date has not yet been assigned.

MDL Case Count Reaches 8,257

January 16, 2026

As of January 2026, the Paraquat class action MDL includes 6,476 pending cases, with a total of 8,257 cases filed.

Over 1,600 Paraquat claims are pending in Pennsylvania, with one case scheduled for trial on January 26th.

More Paraquat Lawsuit Updates Back to the Beginning of the Litigation

MDL Case Count Decreasing as Cases Settle

December 9, 2025

The number of pending cases in the Paraquat class action MDL decreased by 499 in November. This decline is expected to continue as more plaintiffs accept settlement offers.

MDL Case Count Update

November 3, 2025

With the stay extended through January, no new cases were added to the Paraquat MDL in the past month. However, 3 cases were dismissed, reducing the total number of pending cases to 6,442.

Stay Extended to… January

October 2, 2025

The MDL judge has extended the stay in the MDL in hopes of reaching a settlement agreement. The stay on case-specific discovery will now continue through January 5, 2026, to facilitate ongoing settlement negotiations.

Latest MDL Case Count

October 1, 2025

There are currently 6,445 lawsuits pending in the MDL.

Stay Ends on Friday

September 24, 2025

The pause on advancing these cases will end on Friday, after which case-specific discovery is expected to resume unless a settlement is reached or the judge extends the stay further. The discovery hold began in May.

New Lawsuit

September 14, 2025

As the MDL awaits potential settlement, the number of lawsuits continues to grow, now totaling 6,362.

Even as settlement talks in the MDL continue, new lawsuits are still being filed. In a recent lawsuit, a Georgia resident alleges developing Parkinson’s disease due to prolonged exposure to Paraquat-based herbicides.

The complaint, filed directly in the MDL, states that the plaintiff regularly mixed and sprayed Paraquat while performing landscaping work from 2008 to 2017, resulting in direct skin contact on numerous occasions. The plaintiff claims they were never informed about the potential harm of using Paraquat as directed.

MDL Case Count

September 10, 2025

A New York Times article highlights growing evidence that Paraquat exposure is contributing to America’s Parkinson’s crisis.

The article cites newly uncovered company records showing that manufacturers were aware of the herbicide’s harmful effects on the nervous system decades ago but continued to aggressively market it while minimizing the risks. Scientists now consider Parkinson’s a man-made epidemic, largely driven by pesticides like Paraquat, and note that regulators in Europe, China, and numerous other countries have banned the chemical.

The Times article reinforces the claims made in lawsuits: Paraquat is dangerous, and the companies that profited from it should be held accountable.

What Is the Latest on the Paraquat MDL Settlement?

August 12, 2025

Judge Nancy Rosenstengel has extended the stay on all case-specific deadlines in the Paraquat MDL until September 26, 2025, which keeps three bellwether cases in limbo. This marks the third such pause since April, when the parties announced a settlement in principle to resolve thousands of Parkinson’s disease claims against Syngenta and Chevron.

While much of the settlement framework is in place, progress has slowed due to objections or resistance to certain terms from some plaintiff firms, preventing full agreement.

If the settlement is not finalized by late September, case-specific discovery will resume, with the first bellwether trial nominally set for October 14, 2025, and a second for April 6, 2026. However, a resolution is still expected, and the deal is likely to be finalized.

Why Weeding Out Weak Paraquat Lawsuits Benefits You

August 8, 2025

There is ongoing discussion within the Paraquat MDL regarding the dismissal of certain cases. Some defense attorneys, and even a few on the plaintiffs’ side, have criticized the filing practices of some firms.

However, the underlying strength of valid Parkinson’s disease claims remains unquestioned. The MDL is functioning as intended by identifying and removing cases that do not meet the necessary evidentiary standards.

Judge Rosenstengel has consistently dismissed or set aside claims that should not have been filed, which allows the litigation to focus on genuine cases. This benefits plaintiffs with real and viable claims. For legitimate Paraquat plaintiffs, the narrowing of the MDL is not a setback but a crucial step toward a more successful resolution.

Pennsylvania Paraquat Docket Rises to Over 1,100

July 28, 2025

As the MDL navigates a potentially unsteady path toward settlement, the Pennsylvania Paraquat litigation has surpassed 1,100 lawsuits.

For Paraquat victims considering filing a claim, it is important to understand that you do not need to reside in Pennsylvania (or have been exposed to Paraquat there) to participate in this growing docket. Pennsylvania law currently permits individuals from outside the state to file lawsuits in the Philadelphia Court of Common Pleas, even if their exposure occurred elsewhere.

This is not a legal loophole but a strategic approach used by many Paraquat lawyers to avoid delays and uncertainty associated with the federal MDL. The Philadelphia court has experience managing complex mass torts and is moving efficiently, with a dedicated judge and an established framework for resolving these cases. This combination of speed, structure, and judicial experience makes it an appealing venue for many out-of-state plaintiffs seeking to advance their claims without getting lost in a federal backlog.

Effort to Kick Cases Out of Philadelphia

July 17, 2025

Paraquat lawsuits in Philadelphia continue to progress. A Philadelphia state court judge rejected an attempt by Syngenta and Chevron to remove cases from the city’s Paraquat mass tort docket.

The companies argued that plaintiffs residing outside Pennsylvania should refile their claims elsewhere. The motion questioned the court’s ability to manage such extensive litigation, but the court dismissed the motion.

Paraquat MDL Judge Dismisses 116 Cases for Missed Deadlines

June 16, 2025

The court has dismissed 116 lawsuits in the Paraquat MDL for failing to submit required Plaintiff Assessment Questionnaires, following a detailed process outlined in Case Management Order No. 10. Plaintiffs were given multiple opportunities to comply, including formal notices and grace periods, but ultimately failed to meet their obligations.

One plaintiff was spared dismissal after demonstrating that communication issues caused the delay, and the court determined that dismissal would only result in the case being refiled. This ruling underscores a key aspect of mass tort litigation: claimants who miss deadlines risk losing out on potential settlements. However, in many of these cases, the underlying claims are not viable to begin with.

Make America Healthy Again Disappoints on Paraquat

May 22, 2025

Surprisingly, Paraquat was not mentioned in the Make America Healthy Again report on pesticides, despite RFK, Jr.’s extensive involvement in the Paraquat issue.

Chevron and Syngenta’s lobbyists deserve recognition for this omission.

Heading Toward Settlement in the MDL

April 15, 2025

On April 14, 2025, attorneys filed a joint motion requesting the Seventh Circuit to hold their appeal in abeyance. The parties reported that they had entered into a signed settlement framework that could resolve this case and numerous others in the MDL.

Given that this potential resolution could eliminate the need for appellate review, the parties believe a stay would promote judicial efficiency. Judge Rosenstengel has no objections to this request.

They propose submitting a joint status report 60 days after the Court issues its stay order. Depending on the progress, they will either dismiss the appeal or resume proceedings.

New Florida Paraquat Lawsuit

January 22, 2025

A new Paraquat lawsuit filed in the MDL involves a Florida man who alleges that exposure to the herbicide Paraquat caused him to develop Parkinson’s disease. According to the complaint, the plaintiff was regularly exposed to Paraquat from 2013 to 2019 while maintaining property in Hilliard, Florida. During this period, the plaintiff reportedly mixed, applied, and cleaned Paraquat, leading to significant contact with the chemical.

The plaintiff, a retired schoolteacher, engaged in property maintenance activities using Paraquat, including spraying it on their land. The lawsuit states that the plaintiff was exposed to Paraquat through multiple routes, including inhalation, skin absorption, and ingestion of spray droplets. He was diagnosed with Parkinson’s disease in August 2020 but was unaware of the connection between the diagnosis and Paraquat exposure until later. The plaintiff’s spouse has joined the lawsuit, asserting a loss of consortium claim due to the physical and emotional impact the disease has had on their marriage.

RFK Jr.’s Potential Impact on Paraquat Litigation

December 3, 2024

If Robert F. Kennedy, Jr. is confirmed as Secretary of Health and Human Services (HHS)—and this appears likely given the major debates surrounding other nominees—his long-standing advocacy against toxic chemical exposure, including Paraquat, could significantly influence lawsuits linking Paraquat to Parkinson’s disease. Specifically, it might expedite and increase Paraquat settlements.

Spotlight on Robert F. Kennedy Jr.’s Advocacy

Credit must be given where it is due: Robert F. Kennedy Jr. has consistently been a strong voice regarding Paraquat. Nguyen Injury Lawyer believes his influence will likely encourage federal agencies, including the FDA, EPA, and CDC, to thoroughly investigate the health risks associated with Paraquat. This may lead to a reevaluation of current regulations surrounding its use. Furthermore, Kennedy’s advocacy could indirectly support plaintiffs in Paraquat lawsuits by raising public awareness and reinforcing claims of manufacturer negligence.

MDL Selects Replacement Bellwether Cases

November 7, 2024

In the summer of 2024, Judge Rosenstengel issued an order selecting ten cases for specific discovery within the ongoing Paraquat MDL. These cases were being prepared for the initial Paraquat trials in the MDL.

Subsequently, two plaintiffs voluntarily dismissed their complaints within two weeks of being selected. To maintain the established timeline, the Court has chosen two replacement cases:

• Anderson v. Syngenta Crop Protection, LLC, et al. (Case No. 3:23-pq-01712-NJR): The plaintiff, an Illinois farmer, was regularly exposed to Paraquat from approximately 1980 to 2012 via inhalation, ingestion, or skin absorption. During this period, the pesticide was widely available to farmers and businesses in Illinois and applied using both ground-based and aerial spraying methods. The plaintiff received a Parkinson’s disease diagnosis in 2010.
• Powrie v. Syngenta Crop Protection, LLC, et al. (Case No. 3:21-pq-00710-NJR): The plaintiff, residing in Port Jervis, New York, worked as a licensed Paraquat applicator in New York, New Jersey, and Pennsylvania. He frequently mixed, loaded, applied, and cleaned Paraquat products manufactured and sold by the defendants. He was diagnosed with Parkinson’s four years prior.

These replacement cases are subject to the same discovery deadlines as the original selection, ensuring no delays in the proceedings.

Bellwether Cases Dismissed After Expert Exclusion

April 17, 2024

In a significant setback, the MDL judge dismissed the initial four bellwether lawsuits after excluding the testimony of the plaintiff’s key expert on general causation, Dr. Martin Wells.

This decision effectively ended those four cases, as the plaintiffs could not establish the necessary causal link without Dr. Wells’ testimony. The court also granted a summary judgment for the defendants, determining that the plaintiffs’ claims were unsustainable without the expert’s evidence.

Nguyen Injury Lawyer wants you to know that this litigation is not over. Plaintiffs’ legal teams must now develop additional expert support. The court intends to proceed swiftly by selecting a new group of cases for trial. The judge has instructed both parties to choose 16 new cases for limited fact discovery by a specific deadline.

The selection process allocates eight cases to the plaintiffs and four each to Chevron and Syngenta. The selected cases must meet particular criteria, including being filed on or before the date of the judge’s order and having a Plaintiff Assessment Questionnaire that is not materially deficient.

Following the selections, the court will issue a Case Management Order outlining a discovery schedule and setting trial dates.

This is a disheartening development for the initial four plaintiffs. Their only recourse is to appeal the judge’s decision. However, the litigation will continue, and Nguyen Injury Lawyer and other attorneys will work to develop stronger expert evidence to support the well-founded scientific link between Paraquat and Parkinson’s disease.

2017 Illinois Settlements Revealed

March 22, 2024

In 2017, Syngenta faced lawsuits in Illinois state court from individuals diagnosed with Parkinson’s disease. These legal actions were largely unnoticed, as Syngenta aimed to avoid widespread attention and quietly settle the lawsuits confidentially. It has now been revealed that these settlements totaled $187.5 million.

New Study Strengthens Paraquat-Parkinson’s Link

March 7, 2024

A new study reinforces the basis for this litigation: Paraquat exposure can contribute to Parkinson’s disease. The study indicated that individuals with Parkinson’s disease lived and worked closer to areas where Paraquat was used compared to those without the disease. Working near Paraquat annually significantly elevated the risk of developing Parkinson’s disease.

So-called “drifter” cases, involving individuals living near areas with substantial Paraquat use, are often overlooked in this litigation. However, the study demonstrates similar findings for those residing near Paraquat application sites.

Paraquat Lawsuit Overview

Numerous farmworkers and individuals who worked near oil tanks and railroads have filed lawsuits alleging that occupational exposure to the industrial herbicide Paraquat (Gramoxone) caused or contributed to their development of Parkinson’s disease.

There are currently nearly 6,000 Paraquat lawsuits in the MDL, with additional cases being filed in state courts. A Parkinson’s disease class action MDL has been established to manage these claims. In this post, we will examine the potential value of a Paraquat lawsuit by comparing it to settlements in similar mass product cases and prior tort lawsuits involving Parkinson’s disease.

About the Paraquat Lawsuits

Paraquat is a potent industrial herbicide that has been used since the 1960s to control weeds and grasses in agricultural settings. It also functions as a defoliant, removing leaves from trees and plants. Some farmers utilize Paraquat as a desiccant to maintain crop dryness and stability. Chevron began selling Paraquat in the U.S. in 1964.

This chemical is highly toxic; a single teaspoon can be fatal, leading many European countries to ban it entirely. However, Paraquat remains unbanned in the United States and is widely used by large commercial farmers.

Evidence suggests that prolonged Paraquat exposure can lead to early-onset Parkinson’s disease. Studies have revealed that agricultural workers exposed to Paraquat over extended periods have a significantly higher risk of developing Parkinson’s disease. Similarly, individuals residing near farms where Paraquat is applied also exhibit increased rates of Parkinson’s disease.

Paraquat is manufactured by Syngenta, a Swiss agrochemical company. Evidence indicates that Syngenta was aware of the causal link between Paraquat and Parkinson’s for years but intentionally concealed this information. Consequently, farmworkers exposed to Paraquat and subsequently diagnosed with Parkinson’s are filing product liability lawsuits against Syngenta and its U.S. distributors. Contact Nguyen Injury Lawyer at (713) 747-7777.

Thousands of Paraquat Parkinson’s lawsuits have been filed, resulting in the creation of a Paraquat MDL (Paraquat Prod. Liab. Lit., MDL 3004) in the Southern District of Illinois for consolidated handling of these claims.

New calls to ban Paraquat in the UK over Parkinson’s disease risk.

Paraquat Litigation Should Result in a “Global Settlement”

The Paraquat Parkinson’s disease lawsuits are well-progressed in the multidistrict litigation process, with a global settlement appearing increasingly likely. With all federal claims consolidated before a single judge, the MDL has undergone years of coordinated discovery focused on the scientific evidence linking Paraquat exposure to Parkinson’s disease. New cases continue to be added, ensuring the collective advancement of thousands of claims.

Paraquat Lawsuit Settlement Outlook

The next crucial stage involves bellwether trials, where a select group of representative cases will be presented to juries. The outcomes of these bellwether trials will offer the clearest indication of how juries perceive the evidence against Syngenta and the other defendants. Favorable verdicts for the plaintiffs would significantly pressure the companies to settle the remaining claims. Nguyen Injury Lawyer anticipates a global settlement encompassing both the MDL and the growing number of state court cases before any single trial concludes. A trial scheduled for January 2026 will test this prediction.

In mass tort litigation, global settlement negotiations typically commence around this point. A global settlement isn’t just a single sum; it’s a structured agreement that compensates all eligible victims, with amounts varying based on factors like injury severity, age, and the strength of evidence in each case. Considering the established scientific record and the extent of exposure, the Paraquat litigation seems to be heading in that direction.

Key Factors Influencing a Paraquat Lawsuit Settlement

The central point of contention in Paraquat Parkinson’s disease lawsuits revolves around the appropriate settlement compensation amounts. Syngenta, Chevron, and other defendants are striving to minimize settlement payouts.

Individual Paraquat settlement amounts will depend on several factors, including:

• The number of Paraquat claims filed and consolidated into the MDL.
• The strength of the scientific evidence linking Paraquat exposure to Parkinson’s disease.
• The results of the initial bellwether trials.

Estimated Paraquat Lawsuit Settlement Payout Amounts

Despite these variables influencing the final payout value of Paraquat cases, Nguyen Injury Lawyer can offer an estimated range for individual Parkinson’s disease settlement payouts. This is based on settlement payouts in previous mass torts and an assessment of the likelihood that a jury would find the Paraquat defendants liable. We also consider settlement compensation for Parkinson’s disease in tort cases generally.

Based on these comparisons, our attorneys estimate the likely settlement payouts for Paraquat claims as follows:

Settlement Tier	Estimated Settlement
Tier I	$400,000 – $1,000,000+
Tier II	$150,000 – $300,000
Tier III	$20,000 – $150,000

It’s important to remember that these are expected Paraquat settlement amounts, not trial values. A successful verdict in an individual Paraquat lawsuit could be significantly higher, potentially exceeding $10 million, with the possibility of substantial punitive damages.

In comparison, the average successful verdict in Roundup lawsuits exceeded $500 million. In the 3M earplug lawsuit, where the claim involves hearing-related injuries, the average individual jury payout is over $10 million. Given that Parkinson’s disease is a more severe condition, an average jury compensation payout estimated at $10 million might be conservative.

Nguyen Injury Lawyer anticipates that the average Paraquat settlement will fall within the $600,000 to $900,000 range, although the MDL average may be lower. The final position within that range will largely depend on the minimum viability threshold set by the defendants. They may opt for a settlement encompassing all plaintiffs or focus solely on the strongest cases. We believe the latter is more likely, which would reduce the average payout.

Looking ahead to 2026, we anticipate that victims will receive more substantial Paraquat settlements than currently predicted, although the MDL average will be affected by a number of less clear-cut cases. We expect that many cases will surpass the million-dollar settlement mark.

These projections are more applicable to state court cases than the MDL. Cases in state court, particularly in Pennsylvania, are expected to have higher average per-person settlement amounts compared to Paraquat lawsuits filed in the MDL.

Settlement Amounts in Lawsuits Involving Parkinson’s Disease

Another point of comparison for valuing Paraquat cases is the settlement value of other tort cases where Parkinson’s disease was the primary injury.

Parkinson’s disease is challenging to value due to its uncommon occurrence in personal injury claims. Camp Lejeune Parkinson’s disease lawsuits are also being filed, but there are only two settlement amounts available so far (average settlement: $325,000) in that litigation.

Therefore, we can look at tardive dyskinesia, which is similar enough that settlement amounts in those lawsuits might give us a lens to Parkinson’s disease settlement amounts. Nguyen Injury Lawyer has experience in those cases. Let’s examine settlement amounts and jury payouts for tardive dyskinesia as a comparable injury to Parkinson’s disease.

• Watters v Qin (Arizona 2024) $335,669 Verdict: The defendant allegedly stalked the plaintiff (a justice of the peace), slashed her tires, drove by her house shouting threats, trespassed on her property, and engaged in other harassment. The plaintiff claimed the stress exacerbated her pre-existing Parkinson’s disease. This provides insight into how a jury values “Parkinson’s symptoms aggravation.”
• Axe v Spring Meadows (Pennsylvania 2018) $215,000 Settlement: The 73-year-old plaintiff alleged he developed tardive dyskinesia from medications administered by a nursing home. The reason for the relatively low settlement payout is unclear.
• Plaintiff v Defendant (New York 2017) $1,400,000 Settlement: The plaintiff (mid-30s) developed tardive dyskinesia from antipsychotic medication used to treat her bipolar disorder and sued the prescribing doctor.
• Soref v Agresti (Florida 2017) $569,000 Verdict: A female in her mid-20s with a history of drug abuse claimed bipolar drugs caused her to develop tardive dyskinesia.
• Tamaraz v Lincoln Electric (Ohio 2007) $20,500,000 Verdict: This rare jury payout involved a Parkinson’s disease case. The plaintiff filed a welding rod product liability lawsuit alleging he developed Parkinson’s disease from exposure to manganese in welding rods. The jury awarded $17.5 million to him and $3 million to his wife. This verdict underscores the potential for substantial compensation in a Parkinson’s disease case, which is a significant concern for the defendant.

These cases, particularly the welding rod case, suggest the type of verdict we might see in Paraquat bellwether trials. These compensation awards support the settlement payout valuation estimates above.

Paraquat Lawsuits Can Be Filed Decades After Exposure

If you have recently been diagnosed with Parkinson’s disease that you believe is related to Paraquat exposure, you can still file a lawsuit today, even if the exposure occurred years or even decades ago. All states have statutes of limitations that set a deadline for filing civil tort actions, such as product liability claims. The statute of limitations period for a tort claim typically ranges from 1 to 7 years, depending on the state.

However, the statute of limitations period does not begin until the plaintiff knew or should have known that they had a claim. In a Paraquat lawsuit, this means that the period would not start until the plaintiff knew or “should have known” that they had Parkinson’s disease and that it might have been caused by Paraquat exposure.

The connection between Paraquat exposure and Parkinson’s disease is not something that a reasonable person would be expected to know. This is especially true because the companies that manufactured and sold Paraquat deliberately failed to warn about the link. Most plaintiffs in the Paraquat and Parkinson’s disease litigation are bringing claims based on exposure that occurred long ago.

Link Between Paraquat and Parkinson’s Disease

Parkinson’s disease is a progressive neurodegenerative disorder of the brain that primarily affects the motor system, which controls movement.

The primary motor symptoms of Parkinson’s disease include resting tremor, bradykinesia (slowness in voluntary movement and reflexes), rigidity, and postural instability. Currently, there is no cure for Parkinson’s disease. Existing treatments can only temporarily and partially relieve the motor symptoms and do not slow or stop the progression of the disease. These treatments also have unwanted side effects with long-term use.

Paraquat is a toxic chemical and highly effective plant killer. Unfortunately, the same properties that make it toxic to plant cells also make it highly damaging to human nerve cells, posing a significant risk to anyone who uses it.

Oxidative stress is a major factor, if not the primary cause, in the degeneration and death of dopaminergic neurons, which is the main cause of Parkinson’s disease. Paraquat is designed to injure and kill plants by creating oxidative stress, which causes or contributes to the degeneration and death of plant cells. Similarly, Paraquat injures and kills animals by creating oxidative stress, which causes the degeneration and death of animal cells.

The causal link between Paraquat and Parkinson’s disease is well-established. Numerous animal studies involving various routes of exposure have found that Paraquat creates oxidative stress that results in pathophysiology consistent with that seen in human Parkinson’s disease.

Many epidemiological studies have also found an association between Paraquat exposure and Parkinson’s disease, including multiple studies finding a two-to-five-fold or greater increase in the risk of Parkinson’s disease in populations with occupational exposure to Paraquat compared to those without such exposure.

You do not have to work on a farm to have a viable Paraquat lawsuit. Researchers in an article in the American Journal of Epidemiology found that exposure to Paraquat or Maneb within 1600 feet of your home causes a 75% increase in the risk of getting Parkinson’s disease.

Here are some key articles on Paraquat exposure and Parkinson’s disease, along with a summary of their findings:

• Pezzoli, G., & Cereda, E. (2013). Exposure to pesticides or solvents and risk of Parkinson’s disease. Neurology, 80(22), 2035–2041. This study examined environmental exposures and Parkinson’s disease risk, including pesticides such as Paraquat. The researchers found that pesticide exposure was associated with an increased risk of Parkinson’s, particularly when combined with genetic susceptibility. The study supports the role of gene–environment interactions in Parkinson’s disease.
• Berry, C., La Vecchia, C., & Nicotera, P. (2010). Paraquat and Parkinson’s disease. Cell Death & Differentiation, 17(7), 1115-1125. This study looked at the’ role of pesticides in causing Parkinson’s disease. The researchers report that acute chemical exposure was “sufficient” to cause Parkinson’s.
• Costello, S., et al.

If you believe you have a Paraquat lawsuit, contact Nguyen Injury Lawyer today for a free consultation. Our phone number is (713) 747-7777, and our website is https://www.nguyeninjurylawyer.com. You can also reach us through our contact page at https://www.nguyeninjurylawyer.com/contact.

Paraquat and Parkinson’s Disease: Scientific Studies

Numerous scientific studies have explored the potential link between paraquat exposure and Parkinson’s disease. Some key findings from these studies include:

• American Journal of Epidemiology (2009): This study investigated the connection between residential proximity to farms using pesticides and the risk of Parkinson’s disease. The researchers discovered that individuals residing within 500 feet of farms employing paraquat and maneb experienced a 75% increase in Parkinson’s risk. Younger individuals (under 60) faced a significantly elevated risk. The study concluded that exposure to paraquat and maneb, either individually or in combination, significantly heightened the likelihood of developing Parkinson’s disease.
• The Lancet Neurology (2003): This report emphasized the need for a multidisciplinary approach to understanding the etiology of Parkinson’s disease. It suggested that such an approach would aid in determining whether environmental exposures, like paraquat, could contribute to the development of the disease.
• Archives of Neurology (2005): This case-control study examined the association between pesticide exposure and Parkinson’s disease. Researchers interviewed 250 Parkinson’s patients and 388 control subjects, assessing their self-reported pesticide exposures and categorizing them by occupation. The study revealed that pesticide workers were more prone to developing Parkinson’s compared to crop, animal, and dairy farmers. The researchers concluded that these findings aligned with other studies indicating a link between pesticides and Parkinson’s.
• Regulatory Toxicology and Pharmacology (2012): This report analyzed two studies that assessed the association between pesticide exposure and Parkinson’s disease. The researchers criticized the studies for inadequate designs and small sample sizes of exposed patients, noting inconsistent results. They concluded that these studies failed to establish a definitive link between pesticides and Parkinson’s, calling for more rigorous research.
• Neurobiology of Disease (2002): This study explored whether paraquat exposure could induce Parkinson’s disease symptoms in mice. Mice injected with paraquat experienced dopaminergic neuron death, a hallmark of Parkinson’s disease. The researchers concluded that these findings demonstrated paraquat’s neurotoxicity and its significant physiological impact on Parkinson’s-related symptoms.
• JAMA (2000): This article highlighted the association between exposure to pesticides in home or garden settings and the development of Parkinson’s disease.
• The FASEB Journal (2018): This study investigated the mechanisms by which pesticide exposure disrupts cells, mimicking the effects of Parkinson’s-associated mutations. The researchers identified a gene that triggers mitochondrial transport deficits during pesticide exposure. One of the authors stated, “People exposed to these chemicals are at about a 250-percent higher risk of developing Parkinson’s disease than the rest of the population.” This suggests that a significant portion of Parkinson’s cases linked to paraquat exposure might not have occurred otherwise.
• Environmental Health Perspectives (2011): This study examined the association between pesticides causing oxidative stress or mitochondrial dysfunction and Parkinson’s disease in humans. The researchers found that both paraquat and rotenone were linked to an increased risk of Parkinson’s.
• Neurotoxicology (2002): This study explored a model to understand how environmental factors and genetic susceptibility contribute to the molecular basis of idiopathic Parkinson’s disease. The researchers discovered that certain pesticides and metals induced conformational changes in alpha-synuclein and accelerated the rate of alpha-synuclein fibril formation.
• Journal of Toxicology and Environmental Health, Part B (2019): This systematic review and meta-analysis examined the existing literature on paraquat exposure and Parkinson’s disease. The researchers concluded that while current data suggests a positive association between paraquat exposure and Parkinson’s, the evidence was insufficient to establish a causal relationship, calling for better-designed studies.

Consult a Nguyen Injury Lawyer About Paraquat Exposure

If you are considering a paraquat Parkinson’s disease lawsuit, contact Nguyen Injury Lawyer to discuss your potential claim and legal options. Call our toxic exposure lawyers at (713) 747-7777 or visit our contact page for a free online consultation.